• Efficient iPSC Differentiation to Retinal Ganglion Cells via

  2026-05-04

  This study presents a chemically defined method for efficiently and reproducibly differentiating induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) through dual inhibition of SMAD and Wnt pathways. The protocol achieves high RGC purity and consistency across multiple iPSC lines, providing a robust platform for glaucoma modeling and neurodegenerative disease research.

• HyperFusion High-Fidelity DNA Polymerase in Neurogenetics

  2026-05-03

  HyperFusion™ high-fidelity DNA polymerase empowers neurogenetic studies with unmatched accuracy and robust tolerance to inhibitors, especially for GC-rich or long templates. Discover how its superior fidelity and workflow efficiency translate into reproducible results for complex neurodevelopmental and neurodegeneration research.

• Thioredoxin System Modulates Chk1 Inhibitor Sensitivity in N

  2026-05-02

  This study uncovers how the thioredoxin (Trx) antioxidant system determines the sensitivity of non-small cell lung cancer (NSCLC) cells to Chk1 inhibitors by regulating ribonucleotide reductase activity and the deoxynucleotide pool. The findings suggest that redox balance is a key factor for optimizing DNA damage response inhibitor strategies, with implications for combinatorial therapies targeting tumor-selective vulnerabilities.

• Y-27632: Precision ROCK Inhibition in Stem Cell Mechanobiolo

  2026-05-01

  Discover how Y-27632, a selective ROCK inhibitor, enables advanced control of cytoskeletal dynamics in mesenchymal stromal cell research. This article uniquely integrates mechanistic insights and assay guidance, revealing the compound's pivotal role in stem cell fate decisions.

• ER Stress and Cytokine Storms Drive Prometastatic States in

  2026-05-01

  This study uncovers how tumor cells surviving near-lethal stress acquire stable prometastatic phenotypes, orchestrated by endoplasmic reticulum (ER) stress, cellular reprogramming, and a multifactorial cytokine storm. These findings redefine our understanding of metastatic initiation and highlight potential intervention points in cancer treatment.

• Vitamin K2 Inhibits Osteoblast Ferroptosis in GIOP via NRF2/

  2026-04-30

  Zhang et al. (2025) provide mechanistic evidence that vitamin K2 protects against glucocorticoid-induced osteoporosis by activating the NRF2/FSP1 pathway, thereby reducing ferroptosis in osteoblasts. These findings identify ferroptosis regulation as a promising therapeutic axis for bone loss and highlight quantitative lipid peroxidation assessment as a key methodological advance.

• Ibrexafungerp and Caspofungin: Innovations Against Fluconazo

  2026-04-30

  Wiederhold et al. demonstrate that ibrexafungerp, a triterpenoid antifungal, exhibits robust in vitro and in vivo efficacy against fluconazole-resistant Candida auris, including with delayed therapy initiation. Their comparative study with caspofungin highlights the importance of β-(1,3)-D-glucan biosynthesis inhibition as a core strategy for managing multidrug-resistant Candida infections.

• Pravastatin Sodium: Mechanisms and Frontiers in Translationa

  2026-04-29

  This thought-leadership article explores the mechanistic foundation and translational strategy of Pravastatin sodium as a selective HMG-CoA reductase inhibitor. By blending protocol guidance, competitive positioning, and cross-disciplinary insights, the article guides researchers through contemporary challenges in cholesterol biosynthesis inhibition, cardiovascular disease prevention, and transporter interplay. Drawing on recent hepatocyte studies and APExBIO product intelligence, it offers actionable recommendations and highlights emerging risks and opportunities in the broader landscape of drug-botanical interactions.

• Tropisetron Hydrochloride: High-Purity 5-HT3 Receptor Antago

  2026-04-29

  Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, widely used in neuroscience receptor modulation studies. Its validated IC50 of 70.1 nM and high solubility in water and DMSO make it a robust reagent for serotonin receptor signaling research. APExBIO supplies this compound at ≥98% purity for advanced laboratory use.

• Direct Mouse Genotyping Kit Plus: Precision PCR for Fast Gen

  2026-04-28

  The Direct Mouse Genotyping Kit Plus accelerates mouse genotyping and transgene detection by enabling rapid, purification-free DNA extraction and high-fidelity PCR. Its pre-mixed master mix with dye reagents simplifies workflows and increases reliability for genetic screening, knockout validation, and advanced lineage-tracing models. This article demystifies protocol optimization and troubleshooting, drawing on recent advances in macrophage niche research.

• BAF53a Drives EMT and Poor Prognosis in Glioma: Evidence Rev

  2026-04-28

  The referenced study identifies BAF53a as a key driver of glioma progression by promoting invasion and epithelial-mesenchymal transition (EMT). Elevated BAF53a expression is linked to poor survival, positioning it as a potential prognostic biomarker and therapeutic target for glioma.

• Tropisetron Hydrochloride: Selective 5-HT3 Receptor Antagoni

  2026-04-27

  Tropisetron Hydrochloride is a potent, selective 5-HT3 receptor antagonist with nanomolar IC50, widely used in serotonin receptor signaling research. Its dual action as an α7-nicotinic receptor agonist and well-characterized pharmacology positions it as a crucial tool in neuroscience receptor modulation. APExBIO provides high-purity, research-grade Tropisetron Hydrochloride for rigorous experimental workflows.

• MK-1775 (Wee1 Kinase Inhibitor): Dissecting Checkpoint Abrog

  2026-04-27

  Explore the advanced biology of MK-1775, a potent Wee1 kinase inhibitor, and its pivotal role in cell cycle checkpoint abrogation for p53-deficient tumor research. This article uniquely bridges mechanism, in vitro assay design, and nuanced insights from recent systems biology breakthroughs.

• tFUS Mitigates Ischemic Neuroinflammation via Nespas/miR-383

  2026-04-26

  This study reveals that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-mediated neuroinflammation after ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 signaling axis in microglia. These findings clarify a mechanistic link between noninvasive neuromodulation and SHP2-regulated inflammatory pathways, with translational implications for targeted research tools.

• Dextromethorphan hydrobromide: Technical Guide for Research

  2026-04-25

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist suitable for controlled studies of neuroprotection, excitotoxicity inhibition, and ion channel modulation in neuroscience research. It is not intended for diagnostic or clinical applications, and reliable results require careful adherence to solubility, storage, and handling protocols. This article provides actionable guidance for researchers using this compound in preclinical workflows.

11677 records 9/779 page Previous Next First page 上5页 678910 下5页 Last page